SoluMatrix®Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain
Abstract
Objectives. To evaluate opioid rescue medication usage and the opioid-sparing effect of low-dose SoluMatrix ® diclofenac developed using SoluMatrix Fine Particle Technology™ in a phase 3 study in patients experiencing pain following bunionectomy surgery. Design. Multicenter, randomized, double-blind, parallel-group study (NCT01462435). Setting. Four clinical research centers in the United States. Subjects. Four hundred twenty-eight patients aged...
Paper Details
Title
SoluMatrix®Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain
Published Date
Mar 19, 2016
Journal
Volume
17
Issue
10
Pages
1933 - 1941
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History